| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/16/1998 | CA2276088A1 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | CA2276085A1 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | CA2227159A1 Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use |
| 07/15/1998 | EP0853126A2 cDNA clone HE8CS41 that encodes a human 7-transmembrane receptor |
| 07/15/1998 | EP0853125A2 cDNA clone HNFJD15 that encodes a human 7-transmembrane receptor |
| 07/15/1998 | EP0853123A1 Purification of DNA by 'cross-flow-filtration' |
| 07/15/1998 | EP0852627A1 Cell death protein |
| 07/15/1998 | EP0852618A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 07/15/1998 | EP0852490A2 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/15/1998 | EP0681477A4 Genetic modification of neural stem cells. |
| 07/15/1998 | CN1187852A Adherence gene from helicobacter pylori polypeptide coded thereby |
| 07/14/1998 | US5780612 Oligonucleotide antiproliferative agent |
| 07/14/1998 | US5780611 Oligonucleotide which binds with double-stranded promoter region of human collagen gene to form triple helix complex |
| 07/14/1998 | US5780596 Isolated binding protein used in detection of malignant cell types |
| 07/14/1998 | US5780447 Recombinant adeno-associated viral vectors |
| 07/14/1998 | US5780300 Contacting human progenitor cells with agonist of notch function to inhibit differentiation of cells and exposing cells to conditions for proliferation |
| 07/14/1998 | US5780287 Photoactivated antiviral and antitumor compositions |
| 07/14/1998 | US5780286 Arginase II |
| 07/14/1998 | US5780245 Polypeptides having a serotonin receptor activity, nucleic acids coding for these polypeptides and uses |
| 07/14/1998 | US5780222 Method of PCR testing of pooled blood samples |
| 07/14/1998 | US5780100 Introducing suspension of particles in evaporable liquid into tubing, allowing particles to settle, removing liquid, rotating tubing to distribute particles, drying |
| 07/10/1998 | CA2219960A1 Cdna clone he8cs41 that encodes a novel 7-transmembrane receptor |
| 07/09/1998 | WO1998029566A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 07/09/1998 | WO1998029565A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 07/09/1998 | WO1998029556A1 Recombinant adenoviral vector expressing antigens associated with colorectal tumors |
| 07/09/1998 | WO1998029555A2 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 07/09/1998 | WO1998029548A1 Human mage-like protein |
| 07/09/1998 | WO1998029544A1 Novel peptide, novel dna, and novel antibody |
| 07/09/1998 | WO1998029541A1 A process of making a compound by forming a polymer from a template drug |
| 07/09/1998 | WO1998029124A1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |
| 07/09/1998 | WO1998022144A3 Complexes of adenovirus with cationic molecules |
| 07/09/1998 | WO1998021334A3 Antibody mg1 recognizing a small subset of human hematopoietic cells |
| 07/09/1998 | WO1998017796A3 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 07/09/1998 | WO1998015635A3 Treatment of cancer using a recombinant poxvirus containing a nucleic acid sequence encoding a cytokine |
| 07/09/1998 | WO1998008542A3 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 07/09/1998 | CA2605707A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/09/1998 | CA2275975A1 Human mage-like protein |
| 07/08/1998 | EP0851936A1 Method of transgene expression and secretion in schistosoma |
| 07/08/1998 | EP0851935A2 Dna construct comprising a muscle specific regulatory element for immunization or gene therapy |
| 07/08/1998 | EP0851929A1 CYTIDINE DEAMINASE cDNA AS A POSITIVE SELECTABLE MARKER FOR GENE TRANSFER, GENE THERAPY AND PROTEIN SYNTHESIS |
| 07/08/1998 | EP0851927A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/08/1998 | EP0851924A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 07/08/1998 | EP0851923A2 Fmr1-related protein |
| 07/08/1998 | EP0851921A1 Genetic alterations related to familial alzheimer's disease |
| 07/08/1998 | EP0851918A2 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 07/08/1998 | EP0851869A1 Breast specific genes and proteins |
| 07/08/1998 | EP0851769A1 Gene therapy using ovine adenoviral vectors |
| 07/08/1998 | EP0851764A1 Heat shock protein-based vaccines and immunotherapies |
| 07/08/1998 | EP0820526A4 Coding sequences of the human brca1 gene |
| 07/08/1998 | EP0571538B1 Structural gene of pneumococcal protein |
| 07/08/1998 | CN1187118A Oral delivery of gene constructs |
| 07/07/1998 | US5777193 Animals with targeted gene disruption |
| 07/07/1998 | US5777097 Oligonucleotides comprising a region of a cytokine suppressive anti-inflammatory drug binding protein |
| 07/07/1998 | US5776968 Therapeutic uses of melanin |
| 07/07/1998 | US5776910 Dna molecule codes and fc receptors |
| 07/07/1998 | US5776908 Cationic compounds used as carriers for delivery of macromolecules |
| 07/07/1998 | US5776750 Amino acid sequences and polypeptides for hybridizing and genes |
| 07/07/1998 | US5776747 Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer |
| 07/07/1998 | US5776743 Method of sensitizing tumor cells with adenovirus E1A |
| 07/07/1998 | US5776732 Isolated, purified polynucleotide sequence encoding a polypeptide |
| 07/07/1998 | US5776729 Human G-protein receptor HGBER32 |
| 07/07/1998 | US5776704 Method of detecting angiogenic protein |
| 07/07/1998 | US5776683 Methods for identifying genes amplified in cancer cells |
| 07/07/1998 | US5776677 Methods of detecting cystic fibrosis gene by nucleic acid hybridization |
| 07/02/1998 | WO1998028625A1 Method for diagnosis and therapy of hodgkin lymphomas |
| 07/02/1998 | WO1998028442A1 Methods for detecting and inhibiting the rna component of telomerase |
| 07/02/1998 | WO1998028421A1 Human oncogene induced secreted protein i |
| 07/02/1998 | WO1998028417A1 Nucleic acid constructs and uses thereof for direct nucleic acid incorporation into cells |
| 07/02/1998 | WO1998028406A1 Method and device for microinjection of macromolecules into non-adherent cells |
| 07/02/1998 | WO1998028334A1 Peptide antagonists of dp transcription factors |
| 07/02/1998 | WO1998027997A1 A method for diagnosis and treatment of inflammatory bowel diseases including crohn's disease and chronic ulcerative colitis |
| 07/02/1998 | WO1998027996A1 A method of treatment and prophylaxis |
| 07/02/1998 | WO1998027819A1 dapE GENE OF HELICOBACTER PYLORI AND dapE- MUTANT STRAINS OF $i(HELICOBACTER PYLORI) |
| 07/02/1998 | WO1998027813A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 07/02/1998 | WO1998008974A3 Catalytic nucleic acid and its medical use |
| 07/02/1998 | CA2276149A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 07/02/1998 | CA2275892A1 Nucleic acid constructs and uses thereof for direct nucleic acid incorporation into cells |
| 07/02/1998 | CA2275474A1 Method and device for microinjection of macromolecules into non-adherent cells |
| 07/02/1998 | CA2274586A1 Methods for detecting and inhibiting the rna component of telomerase |
| 07/02/1998 | CA2272855A1 Method of diagnosis and therapy of hodgkin's lymphomas |
| 07/02/1998 | CA2271715A1 Peptide antagonists of dp transcription factors |
| 07/02/1998 | CA2219265A1 Human cardiac/brain tolloid-like protein |
| 07/01/1998 | EP0850313A2 Improved aav vectors for gene therapy |
| 07/01/1998 | EP0850310A1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 07/01/1998 | EP0850304A1 Cerebellum-derived growth factors, and uses related thereto |
| 07/01/1998 | EP0850301A2 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 07/01/1998 | EP0850300A1 Method of modulating gene expression with reduced immunostimulatory response |
| 07/01/1998 | EP0850250A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 07/01/1998 | EP0850244A1 Toxoplasma gondii glycoconjugates |
| 07/01/1998 | EP0850071A1 Gene therapy for effector cell regulation |
| 07/01/1998 | EP0850070A2 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 07/01/1998 | CN1186518A Human vascular endothelial growth factor 2 |
| 07/01/1998 | CN1186515A 转化生长因子αHI Transforming growth factor αHI |
| 07/01/1998 | CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
| 06/30/1998 | US5773601 Prevention of gene expression |
| 06/30/1998 | US5773580 Human protein kinase c inhibitor homolog |
| 06/30/1998 | US5773571 Peptide nucleic acids |
| 06/30/1998 | US5773570 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 06/30/1998 | US5773290 Neurelated lipocalin and neutrophil gelatinase associated lipocalin promoters contained in an isolated dna fragment which promote gene expression throughout the estrous cycle |
| 06/30/1998 | US5773289 AAV directed targeted integration |